UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

European journal of cancer (1990), 2007-01, Vol.43 (2), p.258-270

2007

Volltextzugriff (PDF)

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

Annals of oncology, 2011-12, Vol.22 (12), p.2546-2555

2011

Volltextzugriff (PDF)

Practical guidance for the management of aromatase inhibitor-associated bone loss

Annals of oncology, 2008-08, Vol.19 (8), p.1407-1416

2008

Volltextzugriff (PDF)

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Annals of oncology, 2006-09, Vol.17 (9), p.1441-1449

2006

Volltextzugriff (PDF)

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer

European journal of cancer (1990), 2004-10, Vol.40 (15), p.2201-2216

2004

Volltextzugriff (PDF)

Never Too Old? Age Should Not Be a Barrier to Enrollment in Cancer Clinical Trials

The oncologist (Dayton, Ohio), 2005-03, Vol.10 (3), p.198-204

2005

Volltextzugriff (PDF)

Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis

European journal of cancer (1990), 2009-03, Vol.45 (4), p.608-617

2009

Volltextzugriff (PDF)

Comprehensive Geriatric Assessment adds information to eastern cooperative oncology group performance status in elderly cancer patients: An Italian Group for Geriatric Oncology Study

Journal of clinical oncology, 2002-01, Vol.20 (2), p.494-502

2002

Volltextzugriff (PDF)

EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer

European journal of cancer (1990), 2003-11, Vol.39 (16), p.2264-2272

2003

Volltextzugriff (PDF)

Comparative activity of antiemetic drugs

Critical reviews in oncology/hematology, 2007-02, Vol.61 (2), p.162-175

2007

Volltextzugriff (PDF)

Anticipatory nausea and vomiting

Supportive care in cancer, 2005-02, Vol.13 (2), p.117-121

2005

Volltextzugriff (PDF)

Abstract P1-14-01: Final results of NorBreast-231, a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel as first-line chemotherapy in patients with advanced breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-14-01

2019

Volltextzugriff (PDF)

Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

Critical reviews in oncology/hematology, 2007-12, Vol.64 (3), p.198-207

2007

Volltextzugriff (PDF)

Cancer-Related Anemia: Pathogenesis, Prevalence and Treatment

Oncology, 2005-01, Vol.68 (Suppl 1), p.3-11

2005

Volltextzugriff (PDF)

Proposal for classifying the acute emetogenicity of cancer chemotherapy

Journal of clinical oncology, 1997-01, Vol.15 (1), p.103-109

1997

Volltextzugriff (PDF)

Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma

Annals of oncology, 2000-03, Vol.11 (3), p.301-306

2000

Volltextzugriff (PDF)

Abstract P3-09-01: NEPA, a fixed-dose combination of netupitant and palonosetron, prevents chemotherapy-induced nausea and vomiting (CINV) more effectively and reduces the impact on daily living for breast cancer patients compared with palonosetron

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P3-P3-09-01

2013

Volltextzugriff (PDF)

Gemcitabine—a safety review

Anti-cancer drugs, 1998-03, Vol.9 (3), p.191-202

1998

Volltextzugriff (PDF)

The frail are not always elderly

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2121-2122

Aapro, Matti S

2005

Volltextzugriff (PDF)

Long-term implications of bone loss in breast cancer

Breast (Edinburgh), 2004-12, Vol.13 (1), p.29-37

Aapro, Matti S.

2004

Volltextzugriff (PDF)

It is too early to know if intelligence determines cancer incidence and survival

Annals of oncology, 2007-01, Vol.18 (1), p.4-5

Aapro, M.S.

2007

Volltextzugriff (PDF)

Erythropoietins should be used according to guidelines

The lancet oncology, 2008-05, Vol.9 (5), p.412-413

2008

Volltextzugriff (PDF)

A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis

Annals of oncology, 2003-02, Vol.14 (2), p.291-297

2003

Volltextzugriff (PDF)

How do we manage patients with refractory or breakthrough emesis?

Supportive care in cancer, 2002-03, Vol.10 (2), p.106-109

AAPRO, Matti S

2002

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(90)
Tagungsberichte
(1)

Sprache

Englisch
(91)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(87)
Science & Technology
(87)
Oncology
(81)
Humans
(78)
Biological And Medical Sciences
(42)
Medical Sciences
(42)
Female
(35)
Aged
(33)
Pharmacology. Drug Treatments
(30)
Middle Aged
(25)
Male
(23)
Antineoplastic Agents - Adverse Effects
(20)
Adult
(18)
Vomiting - Chemically Induced
(18)
Chemotherapy
(17)
Antineoplastic Agents
(16)
Neoplasms - Drug Therapy
(15)
Vomiting - Prevention & Control
(15)
Nausea - Prevention & Control
(14)
Antiemetics - Therapeutic Use
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

Practical guidance for the management of aromatase inhibitor-associated bone loss

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer

Never Too Old? Age Should Not Be a Barrier to Enrollment in Cancer Clinical Trials

Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis

Comprehensive Geriatric Assessment adds information to eastern cooperative oncology group performance status in elderly cancer patients: An Italian Group for Geriatric Oncology Study

EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer

Comparative activity of antiemetic drugs

Anticipatory nausea and vomiting

Abstract P1-14-01: Final results of NorBreast-231, a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel as first-line chemotherapy in patients with advanced breast cancer

Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

Cancer-Related Anemia: Pathogenesis, Prevalence and Treatment

Proposal for classifying the acute emetogenicity of cancer chemotherapy

Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Abstract P3-09-01: NEPA, a fixed-dose combination of netupitant and palonosetron, prevents chemotherapy-induced nausea and vomiting (CINV) more effectively and reduces the impact on daily living for breast cancer patients compared with palonosetron

Gemcitabine—a safety review

The frail are not always elderly

Long-term implications of bone loss in breast cancer

It is too early to know if intelligence determines cancer incidence and survival

Erythropoietins should be used according to guidelines

A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis

How do we manage patients with refractory or breakthrough emesis?

Suchergebnisse filtern